Polley M J, Nachman R L
J Exp Med. 1979 Sep 19;150(3):633-45. doi: 10.1084/jem.150.3.633.
Thrombin-mediated platelet aggregation and release is enhanced by the presence of C3, C5, C6, C7, C8, and C9 of human complement. The interaction of thrombin with its receptor on the platelet membrane initiates activation of complement on the platelet surface. Trypsin-mediated platelet function is not enhanced by the addition of complement, probably because trypsin has no receptor on the platelet surface so activation of complement is triggered in the fluid phase and not on the platelet surface. Activation of complement by thrombin led to production of dimers of the C5b-9 complex on the platelet surface. These complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The mechanism of complement-induced enhancement of platelet function is not clear, however, it probably is mediated via the arachidonic acid transormation pathway because this activity was blocked by known inhibitors of cyclo-oxygenase, namely, aspirin and indomethacin.
人补体的C3、C5、C6、C7、C8和C9可增强凝血酶介导的血小板聚集和释放。凝血酶与其在血小板膜上的受体相互作用,引发血小板表面补体的激活。添加补体不会增强胰蛋白酶介导的血小板功能,这可能是因为胰蛋白酶在血小板表面没有受体,所以补体的激活是在液相中触发的,而非在血小板表面。凝血酶激活补体导致血小板表面产生C5b-9复合物二聚体。这些复合物从血小板膜上洗脱下来,并通过物理化学和形态学方法进行鉴定。然而,补体诱导血小板功能增强的机制尚不清楚,它可能是通过花生四烯酸转化途径介导的,因为这种活性被已知的环氧化酶抑制剂(即阿司匹林和吲哚美辛)所阻断。